Global bacterial acaricide innovation reshapes sustainable pest control strategies
A new biological solution delivers rapid mite control and challenges chemical resistance, signaling a major shift in modern crop protection.
A new bacterial acaricide technology, unveiled on April 2, 2026 during a virtual event attended by over 10,000 viewers, introduces a groundbreaking approach to pest control, with major implications for sustainable agriculture and resistance management.
A biological breakthrough in crop protection
This innovation represents the first fully registered bacterial acaricide globally, developed from plant endophytes and optimized over several years. Its high-concentration formulation enables fast and effective action, offering a viable alternative to conventional chemical acaricides.
Unlike traditional solutions, its mode of action relies on bacterial metabolites that disrupt the mite digestive system, allowing enzymes to enter the bloodstream and impair immune and nervous functions. This multi-target approach significantly reduces resistance development, a critical issue in modern agriculture.
Strong field performance data
Field results show that visible effects begin within three hours, achieving over 95% control within 24 hours and maintaining effectiveness for up to 20 days. Key trial outcomes include:
- 95% control of citrus mites within 3 days
- 85% residual control after 14 days
- 97% aphid control within 24 hours, outperforming standard chemical treatments
Additionally, its impact on ovary division helps reduce pest populations at the source, enhancing long-term control.
Agronomic compatibility and application
The technology integrates well into existing programs, being compatible with most acaricides and foliar fertilizers, though certain combinations should be avoided. Optimal performance occurs above 25°C, but it remains effective even under cooler conditions.
This development targets high-value crops and regions where chemical resistance has reduced efficacy. One key barrier remains farmer perception, as biological products are often seen as slower acting.

